title: Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
authors.affiliation: Division of Medical Oncology, University of Texas Health Science Center at San Antonio 78284, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Elledge
authors.forename: R
authors.initials: R
authors.lastname: Gray
authors.forename: E
authors.initials: E
authors.lastname: Mansour
authors.forename: Y
authors.initials: Y
authors.lastname: Yu
authors.forename: G M
authors.initials: GM
authors.lastname: Clark
authors.forename: P
authors.initials: P
authors.lastname: Ravdin
authors.forename: C K
authors.initials: CK
authors.lastname: Osborne
authors.forename: K
authors.initials: K
authors.lastname: Gilchrist
authors.forename: N E
authors.initials: NE
authors.lastname: Davidson
authors.forename: N
authors.initials: N
authors.lastname: Robert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D009363:Neoplasm Proteins / Q000032:analysis*; D011237:Predictive Value of Tests; D011241:Prednisone / Q000008:administration & dosage; D016016:Proportional Hazards Models; D012306:Risk; D016019:Survival Analysis; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D009363:Neoplasm Proteins; D016159:Tumor Suppressor Protein p53; D003520:Cyclophosphamide; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate